文献速递心外重症与机械循环支持

COVID-19幸存者体外膜氧合后出院早期恢复情况

Early posthospitalization recovery after extracorporeal membrane oxygenation in survivors of COVID-19.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-03-14

五家学术中心回顾性分析2020年3月至5月机械通气的COVID-19患者,比较静脉-静脉体外膜氧合(ECMO)组与非ECMO组出院后120天内的恢复情况。ECMO组机械通气时间更长、出血和血栓事件更多(P < .01),但出院存活率(69.6% vs 70.6%)及出院后120天内物理、心理、认知功能缺陷发生率相似。

要点

  • ECMO组机械通气中位26天(IQR 19.5-41天),非ECMO组13天(IQR 7-20天)。
  • ECMO组出血和血栓事件更多(P < .01),但出院存活率相似(69.6% vs 70.6%)。
  • 217例幸存者中65.0%在120天内有随访记录,ECMO状态不影响功能缺陷发生率。

核心结论

  • COVID-19幸存者在重症监护病房入住后存在显著的躯体、心理和认知功能缺陷。
  • 尽管ECMO组危重症病程更复杂、平均机械通气时间和平均住院时间更长,静脉-静脉ECMO治疗患者的出院存活率及出院后120天内结局与非ECMO组相似。

研究设计与样本

  • 五家学术中心开展回顾性分析,纳入2020年3月至5月收治的机械通气COVID-19患者。
  • 262例机械通气患者与46例静脉-静脉ECMO插管患者进行比较,幸存者可进入多学科重症后康复门诊。
  • 采用经过验证的工具测量躯体、心理和认知功能缺陷,并根据ECMO状态进行比较。

主要发现

  • ECMO组患者更年轻、距离更远,但性别、种族或体重指数无显著差异。
  • ECMO组机械通气时间更长(中位26天[四分位距19.5-41天] vs 13天[四分位距7-20天]),且更常接受吸入性肺血管扩张剂、神经肌肉阻滞、研究性COVID-19治疗、输血和正性肌力药物。
  • ECMO组出血和血栓事件更多(P < .01),但出院存活率相似(69.6% vs 70.6%)。
  • 217例幸存者中65.0%在120天内有记录的随访;总体95.5%居家居住,25.7%恢复工作或日常活动,23.1%仍在使用补充氧气,这些比率根据ECMO状态无显著差异。
  • 躯体、心理和认知功能缺陷的发生率相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to determine the influence of venovenous extracorporeal membrane oxygenation (ECMO) on outcomes of mechanically ventilated patients with COVID-19 during the first 120 days after hospital discharge. METHODS: Five academic centers conducted a retrospective analysis of mechanically ventilated patients with COVID-19 admitted during March through May 2020. Survivors had access to a multidisciplinary postintensive care recovery clinic. Physical, psychological, and cognitive deficits were measured using validated instruments and compared based on ECMO status. RESULTS: Two hundred sixty two mechanically ventilated patients were compared with 46 patients cannulated for venovenous ECMO. Patients receiving ECMO were younger and traveled farther but there was no significant difference in gender, race, or body mass index. ECMO patients were mechanically ventilated for longer durations (median, 26 days [interquartile range, 19.5-41 days] vs 13 days [interquartile range, 7-20 days]) and were more likely to receive inhaled pulmonary vasodilators, neuromuscular blockade, investigational COVID-19 therapies, blood transfusions, and inotropes. Patients receiving ECMO experienced greater bleeding and clotting events (P < .01). However, survival at discharge was similar (69.6% vs 70.6%). Of the 217 survivors, 65.0% had documented follow-up within 120 days. Overall, 95.5% were residing at home, 25.7% had returned to work or usual activity, and 23.1% were still using supplemental oxygen; these rates did not differ significantly based on ECMO status. Rates of physical, psychological, and cognitive deficits were similar. CONCLUSIONS: Our data suggest that COVID-19 survivors experience significant physical, psychological, and cognitive deficits following intensive care unit admission. Despite a more complex critical illness course, longer average duration of mechanical ventilation, and longer average length of stay, patients treated with venovenous ECMO had similar survival at discharge and outcomes within 120 days of discharge.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Taylor LJ, Jolley SE, Ramani C, et al. Early posthospitalization recovery after extracorporeal membrane oxygenation in survivors of COVID-19. J Thorac Cardiovasc Surg. 2022. PMID: 35431034. doi:10.1016/j.jtcvs.2021.11.099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。